Tomasz Rechcinski
Overview
Explore the profile of Tomasz Rechcinski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
281
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bralewska B, Wykrota J, Kurpesa M, Kasprzak J, Cieslik-Guerra U, Wadolowska E, et al.
Kardiol Pol
. 2024 Jul;
82(9):886-888.
PMID: 38988239
No abstract available.
2.
Tomaszewska A, Gonciarz W, Rechcinski T, Chmiela M, Kurdowska A, Krupa A
Sci Rep
. 2024 Mar;
14(1):5764.
PMID: 38459219
The metabolic syndrome, often accompanied by hepatic manifestations, is a high-risk factor for developing cardiovascular disease. Patients with metabolic dysfunction associated with steatohepatic disease (MASDL) are at significant risk of...
3.
Rechcinski T
J Pers Med
. 2023 Jul;
13(7).
PMID: 37511672
The electrocardiogram (ECG), considered by some diagnosticians of cardiovascular diseases to be a slightly anachronistic tool, has acquired a completely new face and importance thanks to its three modern features:...
4.
Wierzbowska-Drabik K, Mozdzan M, Szymczyk K, Broncel M, Rechcinski T
Kardiol Pol
. 2023 Mar;
81(5):520-521.
PMID: 36951598
No abstract available.
5.
Gonciarz W, Lechowicz L, Urbaniak M, Rechcinski T, Chalubinski M, Broncel M, et al.
Sci Rep
. 2022 Nov;
12(1):18284.
PMID: 36316430
Helicobacter pylori (Hp) Gram-negative bacteria cause gastritis or gastric ulcers. They may be involved in the development of systemic diseases i.e. coronary heart disease (CHD). Both Hp infection and CHD...
6.
Gajewski A, Gawrysiak M, Krupa A, Rechcinski T, Chalubinski M, Gonciarz W, et al.
Int J Mol Sci
. 2022 Jun;
23(11).
PMID: 35683034
The Gastric pathogen () may influence the development of coronary heart disease (CHD). induce reactive oxygen species (ROS), which transform cholesterol to 7-ketocholesterol (7-kCh), a CHD risk factor. Acetylsalicylic acid...
7.
Gonciarz W, Tomaszewska A, Krupa A, Rechcinski T, Chalubinski M, Broncel M, et al.
J Clin Med
. 2022 May;
11(9).
PMID: 35566671
Background: Molecular mimicry between (Hp) and the host components resulting in induction of cross-reacting antibodies has been suggested as accessory mechanism in the development of coronary heart disease (CHD). A...
8.
Rechcinski T, Kasprzak J
Cardiol J
. 2021 Jun;
29(6):1020-1027.
PMID: 34060646
In this recent publication review the authors aimed to collect evidence of impact of nonsynonymous single nucleotide polymorphisms (nsSNP) in the renin-angiotensin-aldosterone system on patients' phenotype not only regarding arterial...
9.
Krupa A, Gonciarz W, Rusek-Wala P, Rechcinski T, Gajewski A, Samsel Z, et al.
Int J Mol Sci
. 2021 Apr;
22(7).
PMID: 33806236
Classic atherosclerosis risk factors do not explain all cases of chronic heart disease. There is significant evidence that gut microbiota may influence the development of atherosclerosis. The widespread prevalence of...
10.
Rechcinski T, Szymanska B, Wierzbowska-Drabik K, Chmiela M, Matusiak A, Kurpesa M, et al.
J Clin Med
. 2021 Apr;
10(5).
PMID: 33801199
Background And Objectives: Some experimental studies demonstrated adverse modulation of atherothrombosis by interleukin-1beta (IL-1b). To assess the relationship between the five most common variants of three polymorphisms of the IL1b...